Drug manufacturer recalls Soltice Quick-RUB nationwide due to manufacturing deviations
Ecometics, Inc. recalled Soltice Quick-RUB nationwide due to Current Good Manufacturing Practice (CGMP) deviations. This was a voluntary recall initiated by the manufacturer in February 2023.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall without reported illnesses or injuries. The stated reason is manufacturing practice deviations, representing a precautionary voluntary recall without evidence of consumer harm.
Plain-English summary
Ecometics, Inc. initiated a nationwide recall of Soltice Quick-RUB, which contains menthol (5.1%) and camphor (5.1%), in response to Current Good Manufacturing Practice (CGMP) deviations. The product was distributed in two sizes: 1.33 oz (37g) plastic jars (approximately 23,993 units) and 3 oz (85g) plastic jars (approximately 34,284 units).
The recall was driven by manufacturing deviations identified at the production facility. The specific nature of these deviations is not disclosed in the FDA notice.
Consumers who purchased affected lots should stop using the product and contact their retailer or manufacturer for guidance. This was a voluntary recall initiated by the manufacturer in February 2023 and terminated in June 2023.
The recalled product
- Product
- Soltice Quick-RUB (Menthol 5.1%, Camphor 5.1%) packaged in a) 1.33 oz (37g) plastic jars and b) 3 Oz (85g) plastic jars
- Manufacturer
- Ecometics, Inc.
- Category
- Drug — Topical / OTC
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: a) 0E344A /AA
- exp. date N/A
- b) 2E243A
- Exp. Aug-25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27